FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18986711000001102: Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64280301000001113 Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64280401000001117 Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Generic Sevikar HCT 40mg/5mg/12.5mg tablets true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Amlodipine besilate true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Olmesartan medoxomil true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Is a Sevikar HCT true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has active ingredient Amlodipine true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has active ingredient Olmesartan medoxomil true Inferred relationship Existential restriction modifier
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi Sankyo UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start